Tirzepatide 15mg is a novel dual agonist peptide targeting both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This pharmaceutical-grade compound is supplied as white lyophilized powder with 99% purity for research applications.
The tirzepatide 15mg formulation demonstrates significant potential in metabolic research, particularly in studies related to type 2 diabetes and obesity management. As a dual receptor agonist, it combines the effects of two important incretin hormones in a single molecule, offering unique research opportunities.
Research indicates that tirzepatide 15mg may influence multiple metabolic pathways including: insulin secretion regulation, gastric emptying modulation, appetite suppression, and blood glucose control. These properties make it particularly interesting for studying metabolic disorders.
Our tirzepatide 15mg is produced under strict GMP conditions with comprehensive quality control. Each batch undergoes rigorous analytical testing including HPLC purity verification and mass spectrometry confirmation to ensure research-grade quality.
Important Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Proper laboratory handling procedures should always be followed when working with research compounds.